ArticleMaterials today. Bio2025
Cell-derived extracellular matrix scaffolds augmented with bone marrow aspirate concentrate promote cartilage regeneration.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A comprehensive review of curcumin-based scaffolds in cartilage tissue engineering.Stem cell research & therapy · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to evaluate the effects of cell-derived (BMSCs and chondrocytes) extracellular matrix (ECM) scaffolds incorporating bone marrow aspirate concentrate (BMAC) on cartilage regeneration, and to determine whether BMAC-loaded BMSCs-derived (BM-d) ECM scaffolds were comparable to chondrocytes-derived (Ch-d) ECM scaffolds in terms of cartilage regeneration. In this study, BMSCs and chondrocytes were harvested and isolated, then developed into BM-d and Ch-d ECM scaffolds. The scaffolds were fully immersed in BMAC and subsequently utilized for inducing chondrogenic differentiation in vitro and cartilage regeneration in vivo. The in vitro results demonstrated that chondrogenesis was effectively promoted, accompanied by scaffold biodegradation, in both BM-d and Ch-d ECM groups as culture progressed over time. The ex vivo results, obtained using nude mice, showed that cartilage-like appearance gradually developed and cartilage matrix accumulation gradually increased in both groups over time. However, more significant calcium deposition was observed in the BM-d ECM group as time progressed. After 12 weeks of in vivo cartilage repair, white and smooth cartilage-like tissues had formed in the defect areas of both ECM groups. The regenerated tissues in both ECM groups fully integrated with the surrounding host tissues and exhibited higher mechanical properties compared to those in the microfracture group. Moreover, the in vivo histological and biochemical results indicated that more hyaline-like cartilage regenerated in both ECM groups, whereas more fibrocartilage formed in the microfracture group. In summary, our results suggest that BM-d and Ch-d ECM scaffolds loaded with BMAC can effectively promote cartilage regeneration both in vitro and in vivo, with BM-d ECM scaffolds being comparable to Ch-d ECM scaffolds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.